Because RBP4 and fetuin-A levels determined by immunoblotting were significantly different between samples from patients with active TB and control subjects, we performed further quantitative ELISA to extend the measurements to plasma samples from 14 Japanese patients with active TB and 13 age-, gender-, and ethnicity-matched control subjects. The gene discussed is RBP4; the disease is tuberculosis.